The company develops cancer immunotherapy that leverages synthetic biology and gene engineering to create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously, resulting in more potent and targeted treatments beyond a single target and function. By unlocking the full potential of cell therapies, Refuge Biotechnologies aims to provide physicians with effective treatments to fight cancer.